Professor, Oncologic Sciences, USF-Morsani
Radiation Oncology
Dr. Lawrence B. Berk, MD
|
|
Give Review
Lawrence Berk is an expert in the field of Radiation Oncology. He studied medicine at University of Pittsburgh School of Medicine. Lawrence B. Berk, MD is also a published MD. He has 24 paper published. The most recent paper is: Xerostomia health-related quality of life: NRG oncology RTOG 0537. Lawrence Berk is registered with Medicare.
Publications
- Xerostomia health-related quality of life: NRG oncology RTOG 0537.
- The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck Cancer patients: results of the randomized, placebo-contr...
- Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-Equivalent efficacy, less toxicity, more convenient:...
- Hepatocellular carcinoma: fighting the rising tide.
- Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.
- Radiation therapy as primary and adjuvant treatment for local and regional melanoma.
- Treatment options for limited or symptomatic metastatic melanoma.
- Primer on integrative oncology.
- Reductionism and the failure of radiobiology.
- Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaGlandin E(1...
- RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: Phase 2 results.
- 16,16-Dimethyl prostaGlandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation.
- Systemic pilocarpine for treatment of xerostomia.
- Skin dose study of chest wall treatment with tomotherapy.
- Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: ...
- Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee.
- Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal Cancer: randomized RTOG trial 0315.
- Hypovolemia and dehydration in the oncology patient.
- A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of Cancer cachexia (RTO...
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Cancer Prevention and Control Committee.
- Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).
- Pathophysiology and management of radiation-induced xerostomia.
Schools
University of Pittsburgh School of Medicine
Mercy Hospital Pittsburgh
University Of Pa Health System
Conditions Treated
- Pituitary Gland Cancer
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
University of Pittsburgh Medical Center-Mercy Hospital -
University of Pittsburgh School of Medicine
Drug Facts
| NPI NUMBER | 1447251715 | |
| NPPES Provider LastName | BERK | |
| NPPES Provider FirstName | LAWRENCE | |
| NPPES Provider ZIPCode | 336126601 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 8.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447251715 |
| Last Name Of The Provider | BERK |
| First Name Of The Provider | LAWRENCE |
| View All |
Similar Doctors
|
Dr. Randy Kahn, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Janelle L. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrea M. Trotti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamran A. Ahmed, MD |
|
|
Dr. Eleanor E. Harris, MD |
|
Dr. Janete M. Mills, MD
This Doctor is OpenDoctor Recommended.
|